Stem cell medicine for COVID-19 symptoms
Part of Infections, Lungs & breathing clinical trials.
This trial tests a new medicine made from stem cells to see if it can help people with COVID-19 symptoms. It's for people who are overweight or moderately obese, have had symptoms for a few days, and have tested positive for COVID-19.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- Your body mass index (BMI) is between 25 and 39.9 (overweight to moderately obese).
- You have had COVID-19 symptoms for more than 2 days but less than 10 days.
- You tested positive for COVID-19 on a rapid antigen test within the last 2 hours.
- You have at least two COVID-19 symptoms that are moderate or severe.
- You are not pregnant or able to become pregnant (or have a negative pregnancy test).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 study tests whether donated-from-your-own-fat stem cells can improve outcomes for people who are high risk for getting COVID-19, but who have never had COVID-19 and test negative right now. It may help your immune system and reduce complications if you become infected during the study.
This trial tests whether immune-supporting treatment made from exosomes can help people with critically severe COVID-19 and lung damage. If you qualify, you may receive this therapy as part of the study to see if it improves outcomes.
This trial tests whether donated “recovered patient” plasma (antibodies from people who had COVID-19) can improve outcomes for people hospitalized with COVID-19. It focuses on patients early in their illness who need a small amount of oxygen.
This trial tests donated (allogeneic) fat-derived stem cells to see if they improve outcomes in adults with severe or critical COVID-19. It may help calm severe lung/immune problems, but whether it works and is safe will be studied in this Phase 2 study.
This study tests whether a single infusion of mesenchymal stem cells can help with Long COVID symptoms—without causing serious side effects. It’s for people who are still struggling with COVID-related health problems months after their initial infection.
This trial tests whether injecting stem cells from the womb's blood supply can help treat severe viral pneumonia. It aims to improve recovery for people who are very sick and need hospital care.
Hear when a new COVID-19 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.